56 results
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
9 May 24
Akebia Therapeutics Reports First Quarter 2024 Financial Results
7:03am
, collaborators, vendors and customers operate; manufacturing, supply chain and quality matters and any recalls, write-downs, impairments or other related
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
27 Mar 24
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
8:35pm
Akebia and its partners, collaborators, vendors and customers operate; manufacturing, supply chain and quality matters and any recalls, write-downs
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
14 Mar 24
Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:18pm
and communities in which Akebia and its partners, collaborators, vendors and customers operate; manufacturing, supply chain and quality matters and any
8-K
EX-99.1
vniv r6gx
8 Jan 24
Results of Operations and Financial Condition
8:02am
8-K
EX-99.1
qtgyynpbuh781i g8
8 Nov 23
Akebia Therapeutics Reports Third Quarter 2023 Financial Results
7:33am
8-K
EX-99.1
f1cr6 022s
25 Oct 23
Akebia Receives FDA Acceptance of Resubmission to NDA of
4:06pm
8-K
EX-99.1
yha4huje70yas9r2c10
26 Sep 23
Akebia Announces Approval of Vafseo® (vadadustat) in Australia and Provides Commercial Update
4:47pm
8-K
EX-99.1
zcycshumgoumsvj xb
25 Aug 23
Akebia Therapeutics Reports Second Quarter 2023 Financial Results
8:14am
8-K
EX-99.1
70zino7 j2jcqq8k0
17 Aug 23
Akebia Receives Notification of Deficiency from Nasdaq Regarding Late Form 10-Q Filing
4:09pm
8-K
EX-99.1
pyumlo1zpv67 m06
11 Aug 23
Akebia Therapeutics Provides Update on Form 10-Q Filing
7:35am
8-K
EX-99.1
hhjarlhkpexqz
18 Jul 23
Akebia Therapeutics Completed Type A Meeting with the FDA and Expects to Resubmit Vadadustat NDA in Third Quarter 2023
7:47am
8-K
EX-99.1
d4kh6pbbl01z
7 Jun 23
Regulation FD Disclosure
7:31am
8-K
pqw gca4zhe
30 May 23
Regulation FD Disclosure
7:34am
8-K
EX-99.1
4pvppmn9x9yg548 sl
30 May 23
Regulation FD Disclosure
7:34am
8-K
EX-99.1
muuyk
25 May 23
Entry into a Material Definitive Agreement
8:05am